The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of asciminib in combination with dasatinib, prednisone, and blinatumomab for Ph-positive acute leukemia in adults.
 
Marlise Luskin
Consulting or Advisory Role - Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer
Research Funding - Abbvie (Inst); Novartis (Inst)
 
Mark Murakami
Research Funding - Genentech/Roche; Generate Biomedicines
Patents, Royalties, Other Intellectual Property - Patent 11844800: methods and composition for predicting and preventing relapse of acute lymphoblastic leukemia.
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - Novartis
(OPTIONAL) Uncompensated Relationships - CancerModels.org
 
Julia Keating
No Relationships to Disclose
 
Eunice Wang
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Immunogen; Johnson & Johnson/Janssen; Kite/Gilead; Kura Oncology; Novartis; Qiagen; Rigel; Ryvu Therapeutics; Schrodinger; SERVIER; Stemline Therapeutics; Sumitomo Pharma Oncology; Syndax; Takeda
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo/UCB Japan; DAVA Pharmaceuticals; Pfizer
Other Relationship - Abbvie/Genentech; Gilead Sciences; Gilead Sciences; UpToDate
 
Malgorzata McMasters
No Relationships to Disclose
 
Yael Flamand
No Relationships to Disclose
 
Eric Winer
Consulting or Advisory Role - Curis; Jazz Pharmaceuticals
 
Maximilian Stahl
Consulting or Advisory Role - Boston Consulting Group; Clinical Care Options; Curis Oncology; GlaxoSmithKline; Haymarket; Kymera; Novartis; Sierra Oncology
 
Hunter Smith
No Relationships to Disclose
 
Stella Jaeckle
No Relationships to Disclose
 
Chase Weizer
No Relationships to Disclose
 
Joseph Fleming
No Relationships to Disclose
 
Caner Saygin
No Relationships to Disclose
 
Wendy Stock
Honoraria - Newave Pharmaceutical; servier
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Kura Oncology; Newave Pharmaceutical; Pfizer; SERVIER
Research Funding - Kura Oncology
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Daniel DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)